| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |